GH Research PLC (GHRS) stock
GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.27−0.48 (-2.56%)
Close on Nov 17, 2026Market cap $1.13BP/E –Yield –
GH Research total assets
Total assets on the balance sheet at the end of each period.
GH Research's total assets was $372.35M at Jun 30, 2026. For fiscal 2025 it was $288.23M, up 53.1% from the year before. The highest annual figure on record is $288.23M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $288.23M | +53.1% |
| FY2024 | Dec 31, 2024 | $188.27M | -16.8% |
| FY2023 | Dec 31, 2023 | $226.30M | -11.0% |
| FY2022 | Dec 31, 2022 | $254.36M | -9.1% |
| FY2021 | Dec 31, 2021 | $279.92M | +4634.8% |
| FY2020 | Dec 31, 2020 | $5.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $372.35M | +18.8% |
| Q1 FY2026 | Mar 31, 2026 | $275.27M | -14.1% |
| Q4 FY2025 | Dec 31, 2025 | $288.23M | +53.1% |
| Q3 FY2025 | Sep 30, 2025 | $302.02M | +51.3% |
| Q2 FY2025 | Jun 30, 2025 | $313.43M | +51.4% |
| Q1 FY2025 | Mar 31, 2025 | $320.45M | +47.3% |
| Q4 FY2024 | Dec 31, 2024 | $188.27M | -16.8% |
| Q3 FY2024 | Sep 30, 2024 | $199.61M | -14.2% |
| Q2 FY2024 | Jun 30, 2024 | $206.98M | -13.9% |
| Q1 FY2024 | Mar 31, 2024 | $217.58M | -14.5% |
| Q4 FY2023 | Dec 31, 2023 | $226.30M | -19.2% |
| Q3 FY2023 | Sep 30, 2023 | $232.57M | +3833.8% |
| Q2 FY2023 | Jun 30, 2023 | $240.27M | – |
| Q4 FY2022 | Dec 31, 2022 | $254.36M | – |
| Q4 FY2021 | Dec 31, 2021 | $279.92M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.91M | – |
See a number that looks wrong?